ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 456

AAA-Atpase p97 Regulates Autophagy-Associated Cell Death in Arthritis

Masaru Kato1, Kerstin Klein2, Caroline Ospelt2, Christoph Kolling3, Michihito Kono1, Shinsuke Yasuda1, Renate E. Gay4, Steffen Gay2 and Tatsuya Atsumi1, 1Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan, 2Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, 3Schulthess Clinic, Zurich, Switzerland, 4Center of Experimental Rheumatology, Zurich University Hospital, Zurich, Switzerland

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Autophagy and rheumatoid arthritis, synovium

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Recently we described a hypersensitivity of rheumatoid arthritis synovial fibroblasts (RASF) compared to osteoarthritis synovial fibroblasts to autophagy under conditions of severe endoplasmic reticulum (ER) stress, leading to a massive cytoplasmic vacuolization, the formation of poly-ubiquitinated protein aggeregates and non-apoptotic cell death. Valosin containing protein (p97/VCP) is an ATPase implicated in the degradation of ubiquitin-labelled proteins through the proteasome. We hypothesized that the inhibition of p97 further sensitizes RASF to autophagy-associated cell death due to impaired proteasomal degradation and subsequent overloaded autophagy.

Methods: RASF were transfected with siRNA targeting p97 or treated with the selective p97 inhibitor DBeQ (5 μM). To induce ER stress, RASF were treated with thapsigargin (TG, 5 nM-5 μM). 3-methyladenine (5 mM) was used as an autophagy inhibitor. The distribution of poly-ubiquitinated proteins was evaluated by immunofluorescence microscopy. Cell death was evaluated by flow cytometry using annexin V/propidium iodide staining. Collagen-induced arthritis (CIA) was induced in Lewis rats. Scrambled or p97 siRNA-atelocollagen complexes were injected into ankle joints of rats. Three, seven and eleven days after the injection, CIA was scored from 0 to 4 according to paw thickness and ankle diameter.

Results: Both siRNA-mediated knockdown and inhibition of p97 in RASF boosted a cytoplasmic vacuolization, the formation of poly-ubiquitinated protein aggeregates and cell death under 5 μM TG treatment, and this cell death was inhibited by 3-methyladenine. Smaller amounts of TG (50 or 500 nM) induced a cytoplasmic vacuolization and the formation of poly-ubiquitinated protein aggeregates in p97–inhibited RASF but not in control RASF. Intra-articular injection of p97 siRNA significantly suppressed CIA (Day 3, p = 0.002; Day 7, p = 0.002; Day 11, p = 0.04; n = 6) in rats.

Conclusion: Our data indicate that the inhibition of p97 promotes autophagy-associated cell death in RASF and suppresses CIA in vivo. p97 may be a new potential target in the treatment of arthritis.


Disclosure:

M. Kato,
None;

K. Klein,
None;

C. Ospelt,
None;

C. Kolling,
None;

M. Kono,
None;

S. Yasuda,
None;

R. E. Gay,
None;

S. Gay,
None;

T. Atsumi,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/aaa-atpase-p97-regulates-autophagy-associated-cell-death-in-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology